Dürrwald R

Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.

Antunes L, Rojas-Castro M, Lozano M, ..., Rose AMC, VEBIS SARI VE network team

Influenza Other Respir Viruses 19 (3) e70081 [2025-03-00; online 2025-03-10]

Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024.

Antunes L, Mazagatos C, Martínez-Baz I, ..., Rose AMC, European Hospital Vaccine Effectiveness Group

Influenza Other Respir Viruses 18 (8) e13360 [2024-08-00; online 2024-08-15]

Category: Vaccines Type: Journal article